1. Sperm Cells for Artificial Reproduction and Germ Cell Transplantation
- Author
-
B. Altinkilic, Wolfgang Weidner, Hans-Christian Schuppe, Adrian Pilatz, and Thorsten Diemer
- Subjects
Azoospermia ,endocrine system ,In vitro fertilisation ,urogenital system ,business.industry ,Urology ,medicine.medical_treatment ,Obstructive azoospermia ,urologic and male genital diseases ,medicine.disease ,Sperm ,Intracytoplasmic sperm injection ,Testicular sperm extraction ,Andrology ,Transplantation ,Sperm Retrieval ,Medicine ,business ,reproductive and urinary physiology - Abstract
Sperm retrieval for in vitro fertilization/intracytoplasmic sperm injection is the only medical procedure that enables a man with testicular azoospermia to father a child. In obstructive azoospermia after failed refertilization, microsurgical epididymal sperm aspiration is the gold standard, with retrieval rates up to 100%. In nonobstructive azoospermia (NOA), testicular spermatozoa (spermatids) can be recovered by testicular sperm extraction (TESE) in approximately half of the men. No parameters are available to definitively predict a successful recovery individually, but genetic factors, reduced testicular volume, and high serum follicle-stimulating hormone levels are associated with an unfavorable outcome. Retrieval surgery is well standardized, chiefly performed with microsurgical assistance and without severe local complications. Microsurgically assisted TESE (M-TESE) and TESE that is not microscopically supported in low-chance NOA patients may result in hypogonadism in the long term. In patients with Klinefelter syndrome, the outcome is worse with increasing age. For children before chemotherapy, M-TESE for stem cell preservation must be performed with minimal damage to the testicles.
- Published
- 2014
- Full Text
- View/download PDF